AGWCA
IMGN

Annis Gardner Whiting Capital Advisors’s Immunogen Inc IMGN Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-183
Closed -$5.43K – 969
2023
Q4 		$5.43K Hold
183
– – ﹤0.01% 536
2023
Q3 		$2.9K Buy
+183
New +$3.04K ﹤0.01% 583

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's IMGN Position: Q1 2024 in Review

Annis Gardner Whiting Capital Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 183 shares — an estimated $5.43K sold.

Annis Gardner Whiting Capital Advisors first reported a position in IMGN in Q3 2023 and held it in 2 quarters. The position peaked at $5.43K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Annis Gardner Whiting Capital Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 183 Immunogen Inc shares in Q1 2024, an estimated $5.43K.
  • Annis Gardner Whiting Capital Advisors first reported a position in Immunogen Inc in Q3 2023 and held it in 2 quarters.
  • Annis Gardner Whiting Capital Advisors's Immunogen Inc position peaked at $5.43K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q1 2024, filed 13 May 2024.